Companies /Healthcare

Hims & Hers Health Inc - Class A

NYSE: HIMS Drug Manufacturers - Specialty & Generic
$28.17
▲ $0.46 (+1.66%) today
Markets closed · 12:24am ET

Q3 2025 Earnings

Reported Nov 3, 2025, 4:08pm ET · SEC source
$0.06
Miss −41.00%
EPS · est. $0.10
$599.0M
Beat +3.30%
Revenue · est. $579.8M
−9.9%
Trailing market
HIMS vs S&P since report
2 quarters
Consecutive EPS misses

Market Reaction

% change · around the report
−4%0+4%Nov 3Nov 4report 4:08pm ETearnings−1.6%−6.8%
−4%0+4%Nov 3Nov 4earnings−1.6%−6.8%
HIMS −6.8%S&P 500 −1.6%
−4%0+4%Nov 3Nov 4report 4:08pm ETearnings−2.8%−6.8%
−4%0+4%Nov 3Nov 4earnings−2.8%−6.8%
HIMS −6.8%NASDAQ −2.8%
−15%−10%−5%0Nov 3Nov 11report 4:08pm ETearnings−0.0%−15.4%
−15%−10%−5%0Nov 3Nov 11earnings−0.0%−15.4%
HIMS −15.4%S&P 500 −0.0%
−18%−12%−6%0Nov 3Nov 11report 4:08pm ETearnings−1.6%−15.4%
−18%−12%−6%0Nov 3Nov 11earnings−1.6%−15.4%
HIMS −15.4%NASDAQ −1.6%
−3.60%
Day of report
+2.20%
Next session
−7.10%
One week
−8.39%
30 days

S&P 500 over the same 30 days: +1.55%.

Did HIMS Beat Earnings? Q3 2025 Results

Hims & Hers Health delivered a split verdict in Q3 2025, posting revenue that topped Wall Street's expectations while earnings fell well short, a combination that nonetheless left investors focused on the company's rapid growth trajectory. Revenue came in at $598.98 million, clearing the $579.85 million consensus by 3.30% and representing a 49.2% year-over-year surge, fueled by a 21% jump in subscribers to nearly 2.5 million and a 19% lift in monthly online revenue per subscriber to $80.00. Earnings per share, however, landed at $0.06, missing the $0.10 consensus by 41.00%, as gross margin compressed roughly 500 basis points to 74%, weighed down by shorter shipping cadences in weight loss offerings and higher fulfillment costs. <a href="https://247wallst.com/investing/2025/11/03/live-hims-hers-earnings-coverage/">Following the results closely</a>, the board also authorized a $250 million share repurchase program, signaling confidence in the balance sheet. Management narrowed full-year 2025 revenue guidance to $2.33 billion to $2.35 billion, while projecting Q4 revenue of $605 million to $625 million.

Key Takeaways
  • 49% YoY revenue growth driven by 21% subscriber growth and 19% increase in monthly online revenue per average subscriber
  • Subscribers using personalized treatment plans increased 50% YoY
  • Subscribers utilizing treatment plans targeting multiple conditions increased more than 80% YoY, now representing over 20% of total subscribers
  • Marketing efficiency improved with GAAP marketing expense declining from 45% to 39% of revenue
  • Subscriber growth exceeded 40% YoY excluding impact of ongoing transition within on-demand sexual health
  • Adjusted EBITDA grew 53% YoY to $78.4 million

“This quarter we continued to prove that our vision of helping tens of millions of people around the world access best-in-class, personalized care, from the comfort of their own home is more real than ever. We're building a platform that gets more personal, more proactive, and resonates with more people as we scale.”

Hims & Hers CEO, on the earnings call

Forward Guidance & Outlook

For Q4 2025, the company expects revenue of $605 million to $625 million and Adjusted EBITDA of $55 million to $65 million (9%-10% margin). For full year 2025, guidance was narrowed to revenue of $2.335 billion to $2.355 billion and Adjusted EBITDA of $307 million to $317 million (13% margin). Management expressed growing conviction in achieving 2030 targets of at least $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA, stating opportunities are materializing faster than expected. The Hers brand is expected to scale toward $1 billion in annual revenue in 2026. International markets represent more than $1 billion in annual revenue potential long-term.

HIMS YoY Financials

Q3 2025 vs Q3 2024 · SEC filings Q3 2024 Q3 2025
$0$200.0M$400.0M$600.0M$401.6M$599.0MRevenue$317.9M$442.1MGross Profit$22.4M$11.8MOperating Income$75.6M$15.8MNet Income
$0$200.0M$400.0M$600.0MRevenueGross ProfitOperating IncomeNet Income

HIMS Revenue by Segment

Online Revenue$589.1M+50.0%
Wholesale Revenue$9.9M+10.0%

HIMS Revenue by Geography

United States
Rest of World

Figures from SEC filings and company reports. Not investment advice.